Kairos Pharma (KAPA) : 4-month performance

Ticker: KAPA

Smith Douglas Homes (SDHC) began trading on the NYSE on Thur 11 Jan 24

Smith Douglas Homes Corp. engages in the design, construction, and sale of single-family homes in the southeastern United States.

• Sector(s): Real Estate
• Industry: Real Estate - Development
• Full Time Employees: 364
• Founded in 2008 
• Headquartered in Woodstock, Georgia
• https://smithdouglas.com

Smith Douglas Homes priced 7.7 mln share IPO at $21.00 per share, at the high end of the $18-21 expected range.

Lead Real Estate (LRE) : 4-month performance

 

 

 

• 2 months later

Getty Images (GETY) : 4-month performance

 

Polestar (PSNY) began trading on the Nasdaq on Fri 24 June 22

• Polestar already has more than 55,000 vehicles on the road in China, Europe and the U.S. It has a factory up and running in China and an assembly line set to begin production later this year in a South Carolina factory shared with Volvo.
• Polestar began as a joint venture between Volvo Cars and its Chinese owner Zhejiang Geely in 2017.
• CEO Thomas Ingenlath

First day of trading, June 24, the EV maker’s shares ended the day at $13.00, up 15.8% .

So far, most SPAC mergers with electric vehicle companies haven’t worked out well for investors. Even the relatively more successful cases of Lucid Group, Fisker and Nikola are currently trading at 67%, 69% and 92% below their post-merger highs, respectively. EV truck maker Rivian, which went public via a traditional IPO, has also struggled. Its shares are down 84% from its post-IPO high.

Over the next three years, the company plans to add three vehicles to its current model, the compact Polestar 2 crossover built in China. The additions are a large SUV, the Polestar 3; a midsize crossover, the Polestar 4; and a large sedan, the Polestar 5, which is intended to serve as the brand’s flagship vehicle.

All will be fully electric and all will be offered in the U.S., Europe and China. Polestar plans to build its vehicles in all three regions.

Oscar Health (OSCR) began trading on the NYSE on Wed 3 March 21

Oscar Health is a provider of health insurance coverage serving individuals, families, small businesses, and Medicare users. According to Reuters, the company currently provides for 529,000 customers on its technology platform across 18 states.

In 2020, the company said that its customers increased year-over-year by 75%, thanks to the pandemic increasing the demand for healthcare delivery through online, mobile and at-home methods. The insurtech’s premiums also increased last year to $1.67 billion, representing a 60% increase from the previous year.

• Co-founded by Josh Kushner in 2012, the managing partner of the venture capital firm Thrive Capital, and the son of billionaire real estate developer Charles Kushner.
• Oscar Health made headlines in 2018, when Google parent company Alphabet took an almost 10% stake in the health insurance startup for $375 million.
• The company was named after Kushner’s great-grandfather, an immigrant given the name Oscar at Ellis Island, according to a letter in the filing from Kushner and co-founder Mario Schlosser.

Sector(s): Healthcare

Industry: Healthcare Plans

https://www.hioscar.com

Oscar Health co-founders Josh Kushner and Mario Schlosser.

Virpax Pharma (VRPX) began trading on the Nasdaq on Wed 17 Feb 21

Pennsylvania-based Virpax Pharmaceuticals (VRPX) has priced its IPO of 1.8M common shares at $10.00/share, for gross proceeds of $18M.

The company was founded to create new formulations for the use of existing, approved drugs for various forms of pain management applications.

• Headquarters: West Chester, PA
• Founded: 2016
• virpaxpharma.com

Virpax's drug development pipeline

West Chester, PA-based preclinical stage biopharmaceutical company is focused developing non-opioid and non-addictive pain management products, using new drug delivery systems.

• It has rights to develop and sell a proprietary patented nonsteroid anti-inflammatory Topical Spray Film Delivery Technology for acute musculoskeletal pain (DSF100 or Epoladerm) and for chronic osteoarthritis of the knee (OSF200).
• The company also rights to injectable, long-acting local anesthetic Liposomal (Hydro) Gel Technology for postoperative pain management (LBL100 or Probudur).
• Virpax says that it also has plans on using our proprietary delivery technologies to develop anti-viral therapies as an anti-viral barrier to potentially prevent or reduce the risk or the intensity of viral infections in humans, including,  influenza and SARS-CoV-2.

CarLotz (LOTZ) began trading on the Nasdaq on Fri 22 Jan 21

 CarLotz, Inc. operates as a consignment-to-retail used consignment store.

• Sector(s): Consumer Cyclical
• Industry: Auto & Truck Dealerships
• Full Time Employees: 166
• 8 locations and online sales
• Headquartered in Richmond, Virginia
• http://www.carlotz.com

 

August 09, 2022:  CarLotz (Nasdaq: LOTZ) to merge with Shift Technologies, Inc. (Nasdaq: SFT), a leading end-to-end ecommerce platform for buying and selling used cars.

October 6, 2023, Shift Technologies announced its intentions to file for Chapter 11 bankruptcy. 

Went public through a merger with a Nasdaq-listed special purpose acquisition (SPAC) Acamar Partners Acquisition Corp., a Miami, Florida-based SPAC that was formed in 2018 and went public with a $300 million IPO in 2019.  Acamar Partners was led by private equity investors Juan Carlos Torres Carretero and Luis Ignacio Solorzano Aizpuru.

CarLotz was the third major U.S. online car seller to go public this past year after Vroom (VRM) and Shift Technologies Inc (SFT).

Online sales only account for around 1% of the roughly $840 billion Americans spend annually on used cars. But after numerous U.S. states went into COVID-19 lockdowns, the advantage of socially distant online sales has come into focus.

CarLotz co-founders Michael Bor (left), Will Boland (center) and Aaron Montgomery (right). 

CarLotz founders, from left, Michael Bor, Aaron Montgomery and Will Boland.

Driven Brands Holdings (DRVN) : 4-month performance

 

ProSight Global (PROS) : 4-month performance

CrowdStrike (CRWD) : initiated with a Sell at Citigroup

The stock traded at nearly 24x forward sales with market cap over $13 bln coming into today.

CrowdStrike stock went public in mid-June, after the company priced its initial public offering (IPO) at $34 per share. The equity subsequently rallied as high as $101.88 in late August, before embarking on a steep pullback. Specifically, CRWD is off more than 40% since the aforementioned peak, and touched a record low of $51.61 on Sept. 30.

GSX Techedu (GSX) : 4-month performance

Puyi (PUYI) began trading on the Nasdaq on Thur 28 March 2019

Puyi Inc. provides third-party wealth management services in China. It focuses on mass affluent and emerging middle class population. The company offers wealth management services, corporate finance services, and asset management services. 

• Sector: Financial Services
• Industry: Asset Management
• Full Time Employees: 277
• Founded in 2010 
• Headquartered in Guangzhou, China
• http://www.puyiwm.com

Priced 4.29 mln ADS IPO (low-end of 4.0-6.67 mln share range) at $6.00, in-line with price expectations

Precision BioSciences (DTIL) : 4-month performance

ticker: DTIL

Pinterest (PINS) reported earnings on Thur 1 Aug 2019 (a/h)

** charts before earnings **

** charts after earnings **

Pinterest beats by $0.03, beats on revs; raises FY19 revs guidance above consensus 

Reports Q2 (Jun) loss of $0.06 per share, $0.03 better thanthe S&P Capital IQ Consensus of ($0.09); revenues rose 62.0% year/year to $261.2 mln vs the $237.23 mln S&P Capital IQ Consensus.

Global MAUs increased 30% yr/yr to 300 mln.

Global ARPU increased 29% yr/yr to $0.88.

Co issues raises guidancefor FY19, sees FY19 revs of $1.095-$1.115 bln vs. prior guidance of $1.055-$1.08 bln and vs. the $1.07 bln S&P Capital IQ Consensus.

Tilray (TLRY) reported earnings on Tue 13 Nov 2018 (a/h)

** charts before earnings ** 

• 3 days before

** charts after earnings **

 

 Tilray beats by $0.04, revenue at low end of upside pre-announcement 

• Reports Q3 (Sep) adj. loss of $0.08 per share, $0.04 better than the S&P Capital IQ Consensus of ($0.12); revenues rose 85.2% year/year to $10 mln vs the $10.25 mln S&P Capital IQ Consensus, driven by increased patient demand, bulk sales to other Licensed Producers, and accelerated wholesale distribution in export markets.
• Preannounced rev $10.0-10.5 million vs. $9.9 mln ests last month.
• Total kilogram equivalents sold increased over two-fold to 1,613 kilograms from 684 kilograms in the prior year. Average net selling price per gram was $6.21 (C$7.98) compared to $7.53 (C$9.34) for the three months ended September 30, 2017.

Tricida (TCDA) began trading on the Nasdaq on Thur 28 June 18

Tricida, Inc. focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. 

• Sector(s): Healthcare
• Industry: Biotechnology
• Full Time Employees: 57
• Incorporated in 2013
• Headquartered in South San Francisco, California
• https://www.tricida.com

Casa Systems (CASA) : 4-month performance

Casa Systems is pioneering advanced ultra-broadband 5G solutions for mobile, cable, fixed and converged service providers.

• Sector: Technology
• Industry: Communication Equipment
• Full Time Employees: 1,066
• Founded in 2003 
• Headquartered in Andover, Massachusetts
• http://www.casa-systems.com

=Kala Pharma (KALA) : 4-month performance

Long trade : Veritone (VERI) +100% (9/17)

• Aug. 21:   vol. 1.0M  $11
• Sept. 11;  $22.60  →  +100%

• 3 weeks later

• 1 week later